Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 8/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15502264 | 1.00 | PRKCA (0.47) | PRKCANAAAPSEN1EPHX1TSHR | |
| SCHEMBL14771903 | 1.00 | PRKCA (0.47) | PRKCANAAAPSEN1EPHX1TSHR | |
| SCHEMBL1537680 | 1.00 | PRKCA (0.47) | PRKCANAAAPSEN1EPHX1TSHR | |
| SCHEMBL17803931 | 1.00 | PRKCA (0.47) | PRKCANAAAPSEN1EPHX1TSHR | |
| SCHEMBL10314811 | 0.94 | PRKCA (0.40) | PRKCAPSEN1TSHR | |
| SCHEMBL12966247 | 0.91 | PRKCA (0.40) | PRKCANAAAPSEN1 | |
| SCHEMBL15581038 | 0.88 | PRKCA (0.40) | PRKCAPSEN1 | |
| SCHEMBL15581037 | 0.88 | PRKCA (0.40) | PRKCAPSEN1 | |
| SCHEMBL10260787 | 0.87 | ATM (0.37) | PRKCATSHR | |
| SCHEMBL16154063 | 0.87 | PRKCA (0.35) | PRKCAPSEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | LANDEC CORPORATION | 2010-01-07 | — | — | US | disclosed |
| US-20090263346-A1 | Systems and methods for delivery of drugs | LANDEC CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20090246155-A1 | Compositions and methods for personal care | LANDEC CORPORATION | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263346-A1 | Systems and methods for delivery of drugs | CYCS, CTRC, PPIC | PRKCA 1007/4885NAAA 2560/4885PSEN1 2967/4885 |
| US-20090246155-A1 | Compositions and methods for personal care | PPIC, CYCS, CTRC | PRKCA 439/4885NAAA 3620/4885PSEN1 1630/4885 |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | CYCS, PCCA, CRYAA | PRKCA 889/4885NAAA 702/4885PSEN1 3703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.